InvestSMART

Kazia Therapeutics Limited (ASX: KZA) - Announcements

DELISTED - Current share price for KZA : $0.080

ASX company news and announcements for Kazia Therapeutics Limited (KZA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Kazia Therapeutics Limited (KZA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Kazia Therapeutics Limited (KZA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Kazia Therapeutics Limited (KZA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Kazia AGM recording 12 Nov 2018 10:46AM $0.390 $0.080 fallen by 79.49%
- Appendix 3B & Cleansing Notice 9 Nov 2018 7:09PM $0.400 $0.080 fallen by 80%
- AGM results 8 Nov 2018 12:12PM $0.390 $0.080 fallen by 79.49%
- AGM presentations 8 Nov 2018 9:13AM $0.390 $0.080 fallen by 79.49%
- Kazia November Newsletter 5 Nov 2018 11:38AM $0.390 $0.080 fallen by 79.49%
- Kazia presents to AusBiotech Invest 30 Oct 2018 8:54AM $0.380 $0.080 fallen by 78.95%
- GDC-0084 update 29 Oct 2018 9:42AM $0.380 $0.080 fallen by 78.95%
- Becoming a substantial holder 26 Oct 2018 4:43PM $0.380 $0.080 fallen by 78.95%
- Section 708 notice 24 Oct 2018 10:58AM $0.385 $0.080 fallen by 79.22%
- Appendix 3B and Listing Rules disclosures 24 Oct 2018 10:57AM $0.385 $0.080 fallen by 79.22%
- Kazia Share Purchase Plan 23 Oct 2018 9:28AM $0.385 $0.080 fallen by 79.22%
- Kazia breast mets collaboration with Dana-Farber 22 Oct 2018 8:59AM $0.385 $0.080 fallen by 79.22%
- Reinstatement to Official Quotation 18 Oct 2018 11:19AM $0.430 $0.080 fallen by 81.40%
- Kazia raises $3.4m to progress R&D programs 18 Oct 2018 11:17AM $0.430 $0.080 fallen by 81.40%
- Suspension from Official Quotation 17 Oct 2018 9:22AM $0.430 $0.080 fallen by 81.40%
- Trading Halt 15 Oct 2018 9:11AM $0.430 $0.080 fallen by 81.40%
- Presentation to Finance News Network Investor Event 11 Oct 2018 9:41AM $0.450 $0.080 fallen by 82.22%
- Cantrixil Part A completion 10 Oct 2018 9:51AM $0.450 $0.080 fallen by 82.22%
- Kazia Notice of Meeting 8 Oct 2018 11:05AM $0.450 $0.080 fallen by 82.22%
- Kazia Annual report, Appx 4G, Corporate Governance Statement 8 Oct 2018 11:01AM $0.450 $0.080 fallen by 82.22%
- Kazia change in interest of substantial shareholder 3 Oct 2018 1:06PM $0.450 $0.080 fallen by 82.22%
- Kazia collaborates with St Jude Children's Research Hospital 3 Oct 2018 8:28AM $0.405 $0.080 fallen by 80.25%
- Kazia attains Milestone 1 under Glioblast Purchase Agreement 14 Sep 2018 9:19AM $0.435 $0.080 fallen by 81.61%
- Kazia Appendix 4E and financial report 29 Aug 2018 6:04PM $0.450 $0.080 fallen by 82.22%
- Kazia files shelf registration statement with SEC 20 Jul 2018 8:30AM $0.495 $0.080 fallen by 83.84%

426 - 450 of 476 results

Page 18 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.